Nile Therapeutics, Inc (CAPR)

Last Year

04-May-23 -- 03-May-24

Time Period:

$64.08K Net Amount

Buy:	$64.08K	$2.82 - $2.90
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

17

0

6

+1

0

+2

0

+3

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-Apr-24 1:30 PM View:	23-Apr-24 Option Exercise $22.46K	Musket David B Director		Nile Therapeutics, Inc - CAPR	79% 30.64K to 54.79K	$21.58K 25%	0	$2.82 - $2.90	--	Show Txns Hide Txns

25-Apr-24 9:15 AM View:	23-Apr-24 Option Exercise $41.70K	Collier Earl M Jr Director		Nile Therapeutics, Inc - CAPR	237% 16.86K to 56.86K	$28.30K 59%	0	$2.83	--	Show Txns Hide Txns

16-May-23 7:00 PM View:	12-May-23 Option Exercise $28.84K	Marban Linda Chief Executive Officer Director		Nile Therapeutics, Inc - CAPR	12% 177.85K to 198.6K	0	0	--	--	Show Txns Hide Txns

16-Aug-23 5:00 PM View:	14-Aug-23 Payment of Exercise ($28.85K)	Litvack Frank Director		Nile Therapeutics, Inc - CAPR	14% 116.89K to 133.27K	0	0	--	--	Show Txns Hide Txns

24-Oct-23 9:25 AM View:	23-Oct-23 Option Exercise $3.03K	Bergmann Anthony Chief Financial Officer		Nile Therapeutics, Inc - CAPR	1073% 0.2K to 2.38K	0	0	--	--	Show Txns Hide Txns

10-Oct-23 9:15 AM View:	06-Oct-23 Market Purchase $14.20K	Auwaerter Paul Gisbert Director		Nile Therapeutics, Inc - CAPR	100% 0 to 5.0K	$14.20K 100%	0	$2.84	--	Show Txns Hide Txns